2012
DOI: 10.1016/j.spinee.2012.09.040
|View full text |Cite
|
Sign up to set email alerts
|

Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
63
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 107 publications
(66 citation statements)
references
References 38 publications
2
63
1
Order By: Relevance
“…The ProDisc ® (Synthes, West Chester, PA) lumbar total disc replacement (TDR) trial reported an incidence of 1.2% (1/82) in males undergoing TDR [11] , while the Charité™ (DePuy, Raynham, MA) artificial disc trial reported an incidence of 4% (6/147) in males undergoing either TDR or anterior fusion [12] . A recent retrospective consecutive cohort study implicates the inflammatory reaction associated with recombinant human bone morphogenetic protein-2 (rhBMP-2) use as an adjunct to anterior lumbar interbody fusion (ALIF) at L5-S1 in generating an increased incidence of retrograde ejaculation [13] . A 6.3% incidence (15/239) of retrograde ejaculation was identified in male patients receiving rh-BMP-2 as an adjunct to one (L5-S1) or two (L4-5/L5-S1) level ALIF, as compared to an incidence of 0.9% (2/233) absent rhBMP-2 use in the control arm.…”
Section: Retrograde Ejaculationmentioning
confidence: 99%
“…The ProDisc ® (Synthes, West Chester, PA) lumbar total disc replacement (TDR) trial reported an incidence of 1.2% (1/82) in males undergoing TDR [11] , while the Charité™ (DePuy, Raynham, MA) artificial disc trial reported an incidence of 4% (6/147) in males undergoing either TDR or anterior fusion [12] . A recent retrospective consecutive cohort study implicates the inflammatory reaction associated with recombinant human bone morphogenetic protein-2 (rhBMP-2) use as an adjunct to anterior lumbar interbody fusion (ALIF) at L5-S1 in generating an increased incidence of retrograde ejaculation [13] . A 6.3% incidence (15/239) of retrograde ejaculation was identified in male patients receiving rh-BMP-2 as an adjunct to one (L5-S1) or two (L4-5/L5-S1) level ALIF, as compared to an incidence of 0.9% (2/233) absent rhBMP-2 use in the control arm.…”
Section: Retrograde Ejaculationmentioning
confidence: 99%
“…Vertebral and nonvertebral bone resorption 41,48,55,60,61,156,[164][165][166][167][168][169][170] Graft subsidence 41,60,61,166,171 Urogenital events Retrograde ejaculation 76,[172][173][174][175] Bladder retention 172,175 Wound complications Hematoma No competing financial interests exist.…”
mentioning
confidence: 99%
“…The risk of injury to the superior hypogastric plexus, which in men results in retrograde ejaculation, is reported to be less than 3% (10,46). Retrograde ejaculation is less frequently observed with L4/5 approaches than L5/S1 and also, the incidence is significantly reduced with a retroperitoneal approach compared to a transperitoneal approach (47,48). In contrast to the ALIF studies, retrograde ejaculation in men has not been yet reported for XLIF (31).…”
Section: Complicationsmentioning
confidence: 95%